;PMID: 9642136
;source_file_1781.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..53] = [t:0..53]
;1)sentence:[e:59..120] = [t:59..120]
;2)section:[e:124..158] = [t:124..158]
;3)section:[e:162..271] = [t:162..271]
;4)sentence:[e:275..418] = [t:275..418]
;5)sentence:[e:419..537] = [t:419..537]
;6)sentence:[e:538..816] = [t:538..816]
;7)sentence:[e:818..988] = [t:818..988]
;8)sentence:[e:989..1123] = [t:989..1123]
;9)sentence:[e:1125..1327] = [t:1125..1327]
;10)sentence:[e:1328..1439] = [t:1328..1439]
;11)sentence:[e:1440..1603] = [t:1440..1603]
;12)sentence:[e:1604..1683] = [t:1604..1683]
;13)sentence:[e:1684..1873] = [t:1684..1873]
;14)sentence:[e:1874..1946] = [t:1874..1946]
;15)sentence:[e:1947..2078] = [t:1947..2078]
;16)section:[e:2079..2109] = [t:2079..2109]
;17)section:[e:2113..2157] = [t:2113..2157]

;section 0 Span:0..53
;Biochem Biophys Res Commun. 1998 Jun 18;247(2):383-6.
(SEC
  (FRAG (NNP:[0..7] Biochem) (NNP:[8..15] Biophys) (NNP:[16..19] Res)
        (NNP:[20..26] Commun) (.:[26..27] .) (CD:[28..32] 1998)
        (NNP:[33..36] Jun) (CD:[37..44] 18;247-LRB-) (CD:[44..45] 2)
        (-RRB-:[45..46] -RRB-) (::[46..47] :) (CD:[47..50] 383)
        (HYPH:[50..51] -) (CD:[51..53] 6.)))

;sentence 1 Span:59..120
;Silencing of CYP1A1 expression in rabbits by DNA methylation.
;[72..78]:cyp450:"CYP1A1"
;[104..107]:substance:"DNA"
(SENT
  (NP-HLN
    (NP (NN:[59..68] Silencing))
    (PP (IN:[69..71] of)
      (NP (NN:[72..78] CYP1A1) (NN:[79..89] expression)))
    (PP-LOC (IN:[90..92] in)
      (NP (NNS:[93..100] rabbits)))
    (PP (IN:[101..103] by)
      (NP (NN:[104..107] DNA) (NN:[108..119] methylation)))
    (.:[119..120] .)))

;section 2 Span:124..158
;Takahashi Y, Suzuki C, Kamataki T.
(SEC
  (FRAG (NNP:[124..133] Takahashi) (NNP:[134..135] Y) (,:[135..136] ,)
        (NNP:[137..143] Suzuki) (NNP:[144..145] C) (,:[145..146] ,)
        (NNP:[147..155] Kamataki) (NNP:[156..158] T.)))

;section 3 Span:162..271
;Faculty of Pharmaceutical Sciences, Hokkaido University, N12W6, Kita-ku, 
;Hokkaido, Sapporo, 060-0812, Japan.
(SEC
  (FRAG (IN:[162..169] Faculty) (IN:[170..172] of)
        (NNP:[173..187] Pharmaceutical) (NNPS:[188..196] Sciences)
        (,:[196..197] ,) (NNP:[198..206] Hokkaido) (NNP:[207..217] University)
        (,:[217..218] ,) (NNP:[219..224] N12W6) (,:[224..225] ,)
        (NNP:[226..233] Kita-ku) (,:[233..234] ,) (NNP:[236..244] Hokkaido)
        (,:[244..245] ,) (NNP:[246..253] Sapporo) (,:[253..254] ,)
        (CD:[255..258] 060) (CD:[258..263] -0812) (,:[263..264] ,)
        (NNP:[265..270] Japan) (.:[270..271] .)))

;sentence 4 Span:275..418
;Unlike most experimental animals, treatment of adult rabbits with 
;3-methylcholanthrene (MC) does not induce the expression of the CYP1A1 gene.
;[342..362]:substance:"3-methylcholanthrene"
;[364..366]:substance:"MC"
(SENT
  (S
    (PP (IN:[275..281] Unlike)
      (NP (JJS:[282..286] most) (JJ:[287..299] experimental)
          (NNS:[300..307] animals)))
    (,:[307..308] ,)
    (NP-SBJ
      (NP (NN:[309..318] treatment))
      (PP (IN:[319..321] of)
        (NP (JJ:[322..327] adult) (NNS:[328..335] rabbits)))
      (PP-CLR (IN:[336..340] with)
        (NP
          (NP (NN:[342..362] 3-methylcholanthrene))
          (NP (-LRB-:[363..364] -LRB-) (NN:[364..366] MC)
              (-RRB-:[366..367] -RRB-)))))
    (VP (VBZ:[368..372] does) (RB:[373..376] not)
      (VP (VB:[377..383] induce)
        (NP
          (NP (DT:[384..387] the) (NN:[388..398] expression))
          (PP (IN:[399..401] of)
            (NP (DT:[402..405] the) (NN:[406..412] CYP1A1) (NN:[413..417] gene))))))
    (.:[417..418] .)))

;sentence 5 Span:419..537
;In  this study, we show that DNA methylation plays one of the key roles in
;the  suppression of CYP1A1 gene expression.
;[448..451]:substance:"DNA"
(SENT
  (S
    (PP-LOC (IN:[419..421] In)
      (NP (DT:[423..427] this) (NN:[428..433] study)))
    (,:[433..434] ,)
    (NP-SBJ (PRP:[435..437] we))
    (VP (VBP:[438..442] show)
      (SBAR (IN:[443..447] that)
        (S
          (NP-SBJ (NN:[448..451] DNA) (NN:[452..463] methylation))
          (VP (VBZ:[464..469] plays)
            (NP
              (NP (CD:[470..473] one))
              (PP (IN:[474..476] of)
                (NP
                  (NP (DT:[477..480] the) (JJ:[481..484] key)
                      (NNS:[485..490] roles))
                  (PP (IN:[491..493] in)
                    (NP
                      (NP (DT:[494..497] the) (NN:[499..510] suppression))
                      (PP (IN:[511..513] of)
                        (NP (NN:[514..520] CYP1A1) (NN:[521..525] gene)
                            (NN:[526..536] expression))))))))))))
    (.:[536..537] .)))

;sentence 6 Span:538..816
;S1 nuclease protection assay showed that  the induction of CYP1A1 mRNA by MC
;occurred in rabbit kidney RK13 cells but not  in rabbit lung R9ab cells,
;while aryl hydrocarbon receptor (AhR) and AhR nuclear  translocator (Arnt)
;mRNAs were expressed in both cells at similar levels.
;[597..608]:substance:"CYP1A1 mRNA"
;[612..614]:substance:"MC"
;[694..719]:substance:"aryl hydrocarbon receptor"
;[721..724]:substance:"AhR"
;[730..755]:substance:"AhR nuclear  translocator"
;[757..761]:substance:"Arnt"
;[763..768]:substance:"mRNAs"
(SENT
  (S
    (NP-SBJ
      (NML (NN:[538..540] S1) (NN:[541..549] nuclease)
           (NN:[550..560] protection))
      (NN:[561..566] assay))
    (VP (VBD:[567..573] showed)
      (SBAR (IN:[574..578] that)
        (S
          (NP-SBJ
            (NP (DT:[580..583] the) (NN:[584..593] induction))
            (PP (IN:[594..596] of)
              (NP (NN:[597..603] CYP1A1) (NN:[604..608] mRNA)))
            (PP (IN:[609..611] by)
              (NP (NN:[612..614] MC))))
          (VP
            (VP (VBD:[615..623] occurred)
              (PP-LOC=3 (IN:[624..626] in)
                (NP (NN:[627..633] rabbit) (NN:[634..640] kidney)
                    (NN:[641..645] RK13) (NNS:[646..651] cells))))
            (CC:[652..655] but) (RB:[656..659] not)
            (VP
              (PP-LOC=3 (IN:[661..663] in)
                (NP (NN:[664..670] rabbit) (NN:[671..675] lung)
                    (NN:[676..680] R9ab) (NNS:[681..686] cells))))
            (,:[686..687] ,)
            (SBAR-ADV (IN:[688..693] while)
              (S
                (NP-SBJ-4
                  (NP
                    (NML
                      (NML
                        (NML (NN:[694..698] aryl) (NN:[699..710] hydrocarbon))
                        (NN:[711..719] receptor))
                      (NML (-LRB-:[720..721] -LRB-) (NN:[721..724] AhR)
                           (-RRB-:[724..725] -RRB-)))
                    (NML-1 (-NONE-:[725..725] *P*)))
                  (CC:[726..729] and)
                  (NP
                    (NML
                      (NML (NN:[730..733] AhR) (JJ:[734..741] nuclear)
                           (NN:[743..755] translocator))
                      (NML (-LRB-:[756..757] -LRB-) (NN:[757..761] Arnt)
                           (-RRB-:[761..762] -RRB-)))
                    (NML-1 (NNS:[763..768] mRNAs))))
                (VP (VBD:[769..773] were)
                  (VP (VBN:[774..783] expressed)
                    (NP-4 (-NONE-:[783..783] *))
                    (PP-LOC (IN:[784..786] in)
                      (NP (DT:[787..791] both) (NNS:[792..797] cells)))
                    (PP (IN:[798..800] at)
                      (NP (JJ:[801..808] similar) (NNS:[809..815] levels)))))))))))
    (.:[815..816] .)))

;sentence 7 Span:818..988
;Interestingly, the treatment of R9ab cells with a DNA demethylating agent, 
;5-aza-2'-deoxycitidine, resulted in the induction of the expression of the 
;CYP1A1 gene by MC.
;[868..871]:substance:"DNA"
;[886..891]:substance:"agent"
;[894..916]:substance:"5-aza-2'-deoxycitidine"
;[985..987]:substance:"MC"
(SENT
  (S
    (ADVP (RB:[818..831] Interestingly))
    (,:[831..832] ,)
    (NP-SBJ
      (NP (DT:[833..836] the) (NN:[837..846] treatment))
      (PP (IN:[847..849] of)
        (NP (NN:[850..854] R9ab) (NNS:[855..860] cells)))
      (PP (IN:[861..865] with)
        (NP
          (NP (DT:[866..867] a)
            (ADJP (NN:[868..871] DNA) (VBG:[872..885] demethylating))
            (NN:[886..891] agent))
          (,:[891..892] ,)
          (NP (NN:[894..916] 5-aza-2'-deoxycitidine)))))
    (,:[916..917] ,)
    (VP (VBD:[918..926] resulted)
      (PP-CLR (IN:[927..929] in)
        (NP
          (NP (DT:[930..933] the) (NN:[934..943] induction))
          (PP (IN:[944..946] of)
            (NP
              (NP (DT:[947..950] the) (NN:[951..961] expression))
              (PP (IN:[962..964] of)
                (NP (DT:[965..968] the) (NN:[970..976] CYP1A1)
                    (NN:[977..981] gene)))
              (PP (IN:[982..984] by)
                (NP (NN:[985..987] MC))))))))
    (.:[987..988] .)))

;sentence 8 Span:989..1123
;The results indicate that DNA methylation is one of the  factors involved in
;the loss of the MC-induced expression of the CYP1A1 gene.
;[1015..1018]:substance:"DNA"
;[1082..1084]:substance:"MC"
(SENT
  (S
    (NP-SBJ (DT:[989..992] The) (NNS:[993..1000] results))
    (VP (VBP:[1001..1009] indicate)
      (SBAR (IN:[1010..1014] that)
        (S
          (NP-SBJ (NN:[1015..1018] DNA) (NN:[1019..1030] methylation))
          (VP (VBZ:[1031..1033] is)
            (NP-PRD
              (NP (CD:[1034..1037] one))
              (PP (IN:[1038..1040] of)
                (NP
                  (NP (DT:[1041..1044] the) (NNS:[1046..1053] factors))
                  (VP (VBN:[1054..1062] involved)
                    (NP (-NONE-:[1062..1062] *))
                    (PP-CLR (IN:[1063..1065] in)
                      (NP
                        (NP (DT:[1066..1069] the) (NN:[1070..1074] loss))
                        (PP (IN:[1075..1077] of)
                          (NP
                            (NP (DT:[1078..1081] the)
                              (ADJP (NN:[1082..1084] MC) (HYPH:[1084..1085] -)
                                    (VBN:[1085..1092] induced))
                              (NN:[1093..1103] expression))
                            (PP (IN:[1104..1106] of)
                              (NP (DT:[1107..1110] the) (NN:[1111..1117] CYP1A1)
                                  (NN:[1118..1122] gene)))))))))))))))
    (.:[1122..1123] .)))

;sentence 9 Span:1125..1327
;Thus, it seemed that the binding of the AhR/Arnt complex to the 
;xenobiotic-responsive element (XRE) was inhibited by the hypermethylation of
;CpG  dinucleotides within an XRE core sequence (5'-CGTG-3').
;[1165..1168]:substance:"AhR"
;[1169..1173]:substance:"Arnt"
;[1190..1219]:substance:"xenobiotic-responsive element"
;[1221..1224]:substance:"XRE"
;[1267..1285]:substance:"CpG  dinucleotides"
;[1296..1299]:substance:"XRE"
(SENT
  (S
    (ADVP (RB:[1125..1129] Thus))
    (,:[1129..1130] ,)
    (NP-SBJ (PRP:[1131..1133] it))
    (VP (VBD:[1134..1140] seemed)
      (SBAR (IN:[1141..1145] that)
        (S
          (NP-SBJ-1
            (NP (DT:[1146..1149] the) (NN:[1150..1157] binding))
            (PP (IN:[1158..1160] of)
              (NP (DT:[1161..1164] the)
                (NML (NN:[1165..1168] AhR) (SYM:[1168..1169] /)
                     (NN:[1169..1173] Arnt))
                (NN:[1174..1181] complex)))
            (PP (TO:[1182..1184] to)
              (NP
                (NP (DT:[1185..1188] the)
                  
                  (ADJP (JJ:[1190..1200] xenobiotic) (HYPH:[1200..1201] -)
                        (JJ:[1201..1211] responsive))
                  (NN:[1212..1219] element))
                (NP (-LRB-:[1220..1221] -LRB-) (NN:[1221..1224] XRE)
                    (-RRB-:[1224..1225] -RRB-)))))
          (VP (VBD:[1226..1229] was)
            (VP (VBN:[1230..1239] inhibited)
              (NP-1 (-NONE-:[1239..1239] *))
              (PP (IN:[1240..1242] by)
                (NP-LGS
                  (NP (DT:[1243..1246] the) (NN:[1247..1263] hypermethylation))
                  (PP (IN:[1264..1266] of)
                    (NP (NN:[1267..1270] CpG) (NNS:[1272..1285] dinucleotides)))
                  (PP (IN:[1286..1292] within)
                    (NP
                      (NP (DT:[1293..1295] an) (NN:[1296..1299] XRE)
                          (NN:[1300..1304] core) (NN:[1305..1313] sequence))
                      (NP (-LRB-:[1314..1315] -LRB-)
                          (NN:[1315..1325] 5'-CGTG-3')
                          (-RRB-:[1325..1326] -RRB-)))))))))))
    (.:[1326..1327] .)))

;sentence 10 Span:1328..1439
;To explore this  possibility, we compared the methylation status of XRE in
;R9ab cells with that  in RK13 cells.
;[1396..1399]:substance:"XRE"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[1328..1328] *))
      (VP (TO:[1328..1330] To)
        (VP (VB:[1331..1338] explore)
          (NP (DT:[1339..1343] this) (NN:[1345..1356] possibility)))))
    (,:[1356..1357] ,)
    (NP-SBJ (PRP:[1358..1360] we))
    (VP (VBD:[1361..1369] compared)
      (NP
        (NP (DT:[1370..1373] the) (NN:[1374..1385] methylation)
            (NN:[1386..1392] status))
        (PP (IN:[1393..1395] of)
          (NP (NN:[1396..1399] XRE)))
        (PP-LOC (IN:[1400..1402] in)
          (NP (NN:[1403..1407] R9ab) (NNS:[1408..1413] cells))))
      (PP-CLR (IN:[1414..1418] with)
        (NP
          (NP (DT:[1419..1423] that))
          (PP-LOC (IN:[1425..1427] in)
            (NP (NN:[1428..1432] RK13) (NNS:[1433..1438] cells))))))
    (.:[1438..1439] .)))

;sentence 11 Span:1440..1603
;A bisulfite sequence analysis using genomic DNAs from R9ab cells  showed that
;the CpG site within XRE was highly methylated on both coding and  non-coding
;strands.
;[1442..1451]:substance:"bisulfite"
;[1484..1488]:substance:"DNAs"
;[1522..1525]:substance:"CpG"
;[1538..1541]:substance:"XRE"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1440..1441] A) (NN:[1442..1451] bisulfite)
          (NN:[1452..1460] sequence) (NN:[1461..1469] analysis))
      (VP (VBG:[1470..1475] using)
        (NP
          (NP (JJ:[1476..1483] genomic) (NNS:[1484..1488] DNAs))
          (PP (IN:[1489..1493] from)
            (NP (NN:[1494..1498] R9ab) (NNS:[1499..1504] cells))))))
    (VP (VBD:[1506..1512] showed)
      (SBAR (IN:[1513..1517] that)
        (S
          (NP-SBJ
            (NP (DT:[1518..1521] the) (NN:[1522..1525] CpG)
                (NN:[1526..1530] site))
            (PP (IN:[1531..1537] within)
              (NP (NN:[1538..1541] XRE))))
          (VP (VBD:[1542..1545] was)
            (ADJP-PRD (RB:[1546..1552] highly) (VBN:[1553..1563] methylated))
            (PP (IN:[1564..1566] on)
              (NP (CC:[1567..1571] both)
                (NML
                  (NML (VBG:[1572..1578] coding)
                    (NML-1 (-NONE-:[1578..1578] *P*)))
                  (CC:[1579..1582] and)
                  (NML
                    (ADJP (AFX:[1584..1587] non) (HYPH:[1587..1588] -)
                          (VBG:[1588..1594] coding))
                    (NML-1 (NNS:[1595..1602] strands))))))))))
    (.:[1602..1603] .)))

;sentence 12 Span:1604..1683
;In contrast to this result, the hypomethylation of XRE was  seen in RK13
;cells.
;[1655..1658]:substance:"XRE"
(SENT
  (S
    (PP (IN:[1604..1606] In)
      (NP
        (NP (NN:[1607..1615] contrast))
        (PP (TO:[1616..1618] to)
          (NP (DT:[1619..1623] this) (NN:[1624..1630] result)))))
    (,:[1630..1631] ,)
    (NP-SBJ-1
      (NP (DT:[1632..1635] the) (NN:[1636..1651] hypomethylation))
      (PP (IN:[1652..1654] of)
        (NP (NN:[1655..1658] XRE))))
    (VP (VBD:[1659..1662] was)
      (VP (VBN:[1664..1668] seen)
        (NP-1 (-NONE-:[1668..1668] *))
        (PP-LOC (IN:[1669..1671] in)
          (NP (NN:[1672..1676] RK13) (NNS:[1677..1682] cells)))))
    (.:[1682..1683] .)))

;sentence 13 Span:1684..1873
;To examine whether or not the binding of the AhR/Arnt  heterodimer to XRE is
;affected by the methylation status of XRE, a gel shift  assay using a
;methylated XRE as a probe was carried out.
;[1729..1732]:substance:"AhR"
;[1733..1737]:substance:"Arnt"
;[1739..1750]:substance:"heterodimer"
;[1754..1757]:substance:"XRE"
;[1799..1802]:substance:"XRE"
;[1842..1845]:substance:"XRE"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[1684..1684] *))
      (VP (TO:[1684..1686] To)
        (VP (VB:[1687..1694] examine)
          (SBAR (IN:[1695..1702] whether) (CC:[1703..1705] or)
                (RB:[1706..1709] not)
            (S
              (NP-SBJ-3
                (NP (DT:[1710..1713] the) (NN:[1714..1721] binding))
                (PP (IN:[1722..1724] of)
                  (NP (DT:[1725..1728] the)
                    (NML (NN:[1729..1732] AhR) (SYM:[1732..1733] /)
                         (NN:[1733..1737] Arnt))
                    (NN:[1739..1750] heterodimer)))
                (PP (TO:[1751..1753] to)
                  (NP (NN:[1754..1757] XRE))))
              (VP (VBZ:[1758..1760] is)
                (VP (VBN:[1761..1769] affected)
                  (NP-3 (-NONE-:[1769..1769] *))
                  (PP (IN:[1770..1772] by)
                    (NP-LGS
                      (NP (DT:[1773..1776] the) (NN:[1777..1788] methylation)
                          (NN:[1789..1795] status))
                      (PP (IN:[1796..1798] of)
                        (NP (NN:[1799..1802] XRE))))))))))))
    (,:[1802..1803] ,)
    (NP-SBJ-1
      (NP (DT:[1804..1805] a) (NN:[1806..1809] gel) (NN:[1810..1815] shift)
          (NN:[1817..1822] assay))
      (VP (VBG:[1823..1828] using)
        (NP (DT:[1829..1830] a) (VBN:[1831..1841] methylated)
            (NN:[1842..1845] XRE))
        (PP-MNR (IN:[1846..1848] as)
          (NP (DT:[1849..1850] a) (NN:[1851..1856] probe)))))
    (VP (VBD:[1857..1860] was)
      (VP (VBN:[1861..1868] carried)
        (PRT (RP:[1869..1872] out))
        (NP-1 (-NONE-:[1872..1872] *))))
    (.:[1872..1873] .)))

;sentence 14 Span:1874..1946
;As expected, the  AhR/Arnt complex could not bind to the methylated XRE.
;[1892..1895]:substance:"AhR"
;[1896..1900]:substance:"Arnt"
;[1942..1945]:substance:"XRE"
(SENT
  (S
    (PP (IN:[1874..1876] As)
      (S-NOM
        (NP-SBJ-2 (-NONE-:[1876..1876] *))
        (VP (VBN:[1877..1885] expected)
          (NP-2 (-NONE-:[1885..1885] *)))))
    (,:[1885..1886] ,)
    (NP-SBJ (DT:[1887..1890] the)
      (NML (NN:[1892..1895] AhR) (SYM:[1895..1896] /) (NN:[1896..1900] Arnt))
      (NN:[1901..1908] complex))
    (VP (MD:[1909..1914] could) (RB:[1915..1918] not)
      (VP (VB:[1919..1923] bind)
        (PP-CLR (TO:[1924..1926] to)
          (NP (DT:[1927..1930] the) (VBN:[1931..1941] methylated)
              (NN:[1942..1945] XRE)))))
    (.:[1945..1946] .)))

;sentence 15 Span:1947..2078
;From these results, we  conclude that the cell type-specific transcription of
;the rabbit CYP1A1 gene is  caused by DNA methylation.
;[2062..2065]:substance:"DNA"
(SENT
  (S
    (PP (IN:[1947..1951] From)
      (NP (DT:[1952..1957] these) (NNS:[1958..1965] results)))
    (,:[1965..1966] ,)
    (NP-SBJ (PRP:[1967..1969] we))
    (VP (VBP:[1971..1979] conclude)
      (SBAR (IN:[1980..1984] that)
        (S
          (NP-SBJ-1
            (NP (DT:[1985..1988] the)
              (ADJP
                (NML (NN:[1989..1993] cell) (NN:[1994..1998] type))
                (HYPH:[1998..1999] -) (JJ:[1999..2007] specific))
              (NN:[2008..2021] transcription))
            (PP (IN:[2022..2024] of)
              (NP (DT:[2025..2028] the) (NN:[2029..2035] rabbit)
                  (NN:[2036..2042] CYP1A1) (NN:[2043..2047] gene))))
          (VP (VBZ:[2048..2050] is)
            (VP (VBN:[2052..2058] caused)
              (NP-1 (-NONE-:[2058..2058] *))
              (PP (IN:[2059..2061] by)
                (NP-LGS (NN:[2062..2065] DNA) (NN:[2066..2077] methylation))))))))
    (.:[2077..2078] .)))

;section 16 Span:2079..2109
;Copyright 1998 Academic Press.
(SEC
  (FRAG (NN:[2079..2088] Copyright) (CD:[2089..2093] 1998)
        (NNP:[2094..2102] Academic) (NNP:[2103..2108] Press) (.:[2108..2109] .)))

;section 17 Span:2113..2157
;PMID: 9642136 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2113..2117] PMID) (::[2117..2118] :) (CD:[2119..2126] 9642136)
        (NN:[2127..2128] -LSB-) (NNP:[2128..2134] PubMed) (::[2135..2136] -)
        (NN:[2137..2144] indexed) (IN:[2145..2148] for)
        (NNP:[2149..2157] MEDLINE-RSB-)))
